chronic%20stable%20angina
CHRONIC STABLE ANGINA
Chronic stable angina is a clinical syndrome characterized by squeezing, heaviness or pressure discomfort in the chest, neck, jaw, shoulder, back, or arms which is usually precipitated by exertion and/or emotional stress and relieved by rest and/or Nitroglycerin.
It is caused by myocardial ischemia that is commonly associated with narrowing of the coronary arteries.
Angina is stable when it is not a new symptom and when there is no deterioration in frequency, duration or severity of episodes.

Prevention

Influenza Vaccination

  • Annual influenza vaccination is recommended for patients with ischemic heart disease (IHD) especially the elderly
    • Decreases exacerbation of underlying medical condition and risk for mortality in patients with chronic illnesses such as cardiovascular (CV) disease

Follow Up

  • Patients with stable ischemic heart disease (SIHD) should have regular follow-up every 4-6 months during the first year of therapy and 6-12 months after the first year if the patient is stable and reliable to know when symptoms or functional capacity becomes worse
  • Evaluation includes:
    • Assessment of symptoms and clinical function
    • Surveillance for complications such as arrhythmias and heart failure
    • Monitoring of cardiac risk factors
    • Assessment of the adequacy and compliance to lifestyle modifications and medical therapy
  • Reassessment of prognosis via stress test every 3-5 years for low-risk/asymptomatic patients after warranty of previous stress test
  • Periodic screening of comorbidities that are prevalent in patients with SIHD such as diabetes mellitus (DM), depression, and chronic renal disease
  • Resting electrocardiogram (ECG) at 1-year or longer intervals between studies in patients with stable symptoms can also be performed
    • Additional ECG is suggested if patient experiences arrhythmia, anginal symptoms, or if therapy has been modified
  • Exercise ECG or stress imaging is recommended if there are changes in frequency of symptoms or new symptoms occur
    • Repeat exercise ECG may be done after 2 years if stable
  • Assessment of left ventricular ejection fraction (LVEF) and segmental wall motion by echocardiography or radionuclide imaging is recommended in patients with new or worsening heart failure or evidence of intervening myocardial infarction (MI) by history or ECG
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Christina Lau, 06 Sep 2017

In patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI), dual antithrombotic therapy with dabigatran and a P2Y12 inhibitor significantly reduces bleeding vs triple therapy with warfarin, a P2Y12 inhibitor and aspirin, with comparable rates of thromboembolic events, results of the RE-DUAL PCI trial have shown.

19 Jun 2019
Slideshow: Highlights from the Asian Pacific Society of Cardiology 2019 Congress
Yesterday
A study has recently derived and validated a new index for preoperative cardiovascular evaluation, which can significantly contribute to the efficient triage and management of patients scheduled for noncardiac surgery. The new Cardiovascular Risk Index (CVRI) demonstrates a robust discriminatory power that can effectively stratify patients into low-, intermediate- and high-risk groups.
04 Jun 2019
The addition of alirocumab to intensive statin therapy appears to cut the risk of death following acute coronary syndrome, especially if treatment is sustained for at least 3 years, if baseline low-density lipoprotein cholesterol (LDL-C) is ≥100 mg/dL or if achieved LDL-C is low, according to data from the ODYSSEY OUTCOMES.